Stay updated on Defactinib and VS-6766 in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page.

Latest updates to the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.1%
- Check12 days agoChange DetectedThe trial enrollment has been stopped early due to a lack of significant patient responses, and several key metrics related to disease control and adverse events have been updated or removed, indicating a shift in the study's focus and reporting structure.SummaryDifference13%
- Check19 days agoChange DetectedThe web page now includes a service alert regarding planned maintenance starting July 25th, indicating that most services will be unavailable for over 24 hours beginning at 9 PM EDT.SummaryDifference0.8%
- Check27 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference0.9%
- Check34 days agoNo Change Detected
- Check41 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.SummaryDifference0.7%
- Check55 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
Stay in the know with updates to Defactinib and VS-6766 in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Defactinib and VS-6766 in Uveal Melanoma Clinical Trial page.